Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Basic and Diluted Net Income (Loss) Per Common Share

v3.7.0.1
Note 3 - Basic and Diluted Net Income (Loss) Per Common Share
6 Months Ended
Jun. 30, 2017
Notes to Financial Statements  
Earnings Per Share [Text Block]
NOTE
 -
3
Basic and Diluted Net INCOME (Loss) Per Common Share
 
Milestone Scientific presents "basic" earnings (loss) per common share applicable to common stockholders and, if applicable, "diluted" earnings (loss) per common share applicable to common stockholders pursuant to the provisions of Statement of Financial Accounting Standards ASC Topic
260.
Basic earnings (loss) per common share is calculated by dividing net income or loss applicable to common stockholders by the weighted average number of common shares outstanding and to be issued during each period. The calculation of diluted earnings per common share is similar to that of basic earnings per common share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if all potentially dilutive common shares, such as those issuable upon the exercise of stock options, warrants, and the conversion of debt were issued during the period.
 
Since Milestone Scientific had net losses for
three
months and
six
months ended
June 30, 2017
and
2016,
the assumed effects of the exercise of potentially dilutive outstanding stock options and warrants were
not
included in the calculation as their effect would have been anti-dilutive. Such outstanding options and warrants totaled
3,364,840
and
1,976,677
at
June 30, 2017
and
2016,
respectively.